Showing 6551-6560 of 23150 results for "".
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
https://reachmd.com/programs/neurofrontiers/discussing-the-latest-in-ms-treatment-and-disease-modifying-therapies/15894/Tune in to hear the latest additions to the WHO’s Essential Medicines List for the treatment of multiple sclerosis.Creative Collaborations in Quality Improvement Modeling
https://reachmd.com/programs/lifelong-learning/creative-collaborations-in-quality-improvement-modeling/7206/Quality Improvement in medical education can take place along several stages of behavior change, from orientation to enablement to sustainment. The timing of QI intervention, and the ways in which QI teams collaborate creatively within each phase, become critical. Joining host Alicia Sutton to elaboDeath Rates in the United States Continue to Decrease
https://reachmd.com/programs/the-jama-report/death-rates-united-states-continue-decrease/7731/[Read the Article] Evaluating long-term trends in mortality is important for health planning, priority setting and also to identify modifiable factors contributing to poor health. In a new study, researchers from the American Cancer Society reviewed changes in the overall U.S. death rate, as well asHow an EHR Can Help You Participate in MACRA
https://reachmd.com/programs/perspectives-ama/how-ehr-can-help-you-participate-macra/8368/Information for physicians about the importance of electronic health records(EHRs) to participation in MACRA.Optimizing Outcomes in Endometrial Cancer: From Surgery to Recurrence Management
https://reachmd.com/programs/advances-in-womens-health/optimizing-outcomes-in-endometrial-cancer-from-surgery-to-recurrence-management/36396/Endometrial cancer treatment is continuing to evolve, with surgery guiding initial decisions and new evidence showing that adding immunotherapy significantly improves outcomes in advanced disease. But key questions remain around tailoring regimens to individual patients. Dr. Ann Klopp highlights theClinical Outcomes of Radiation vs. Chemoradiation in Recurrent Endometrial Cancer
https://reachmd.com/programs/advances-in-womens-health/clinical-outcomes-of-radiation-vs-chemoradiation-in-recurrent-endometrial-cancer/37231/The recent NRG0238 trial evaluated whether adding chemotherapy to radiation improves outcomes in patients with localized endometrial cancer recurrences. Hear from Dr. Ann Klopp as she explains the findings and how they could shift practice patterns for patient care. Dr. Klopp is a Professor of RadiaChallenging the Standard of Care in NSCLC: Findings from the TROPION-Lung01 Study
https://reachmd.com/programs/project-oncology/challenging-the-standard-of-care-in-nsclc-findings-from-the-tropion-lung01-study/16360/What role might datopotamab deruxtecan play in treating patients with non-small cell lung cancer? Find out with this recap of a recent study.How the COVID-19 Pandemic Exposed Gaps in US Hospital Preparedness
https://reachmd.com/programs/clinicians-roundtable/how-the-covid-19-pandemic-exposed-gaps-in-us-hospital-preparedness/36413/Hospitals were especially vulnerable during the COVID-19 pandemic, with regulatory barriers, a lack of resources, and disjointed communication compounding the burden of the disease. Tune in to hear Dr. Amesh Adaljia examine the structural and systemic challenges to pandemic preparedness and discussDetecting Recurrent Breast Cancer: The Role of Liquid Biopsies and Molecular Markers
https://reachmd.com/programs/project-oncology/detecting-recurrent-breast-cancer-the-role-of-liquid-biopsies-and-molecular-markers/26407/Here’s a look ahead at how advances in liquid biopsies and molecular markers may help us identify the risk of recurrence in breast cancer patients.An Expert Perspective on Pancreatic Necrosis Management
https://reachmd.com/programs/gi-insights/an-expert-perspective-on-pancreatic-necrosis-management/12700/The approach to managing pancreatic necrosis has evolved. Stay in the know with this clinical practice update.